Asian Spectator

Men's Weekly

.

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

  • Written by ACN Newswire - Press Releases

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

SHANGHAI, CHINA, Jul 20, 2020 - (ACN Newswire) - Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today announced that it has successfully closed US$97 million in Series C financing.

The...

More Articles ...

  1. Top 7 Benefits That a CBD-Rich Oil Can Potentially Offer
  2. Australians concerned about their financial wellbeing as a result of COVID-19
  3. Fivetran Raises $100 Million to Accelerate Growth as Automated Data Integration Leader
  4. Commodities Intelligence Centre (CIC) introduces international Trade Data and Business Services, partners SBF to drive digital transformation of Singapore SMEs

Magazine

Budaya politik tak tahu malu: Mengapa politikus bermasalah enggan mundur dari jabatannya?

Ahmad Sahroni saat memimpin Rapat Kerja Komisi III DPR RI.Fatimahalbar/Wikimedia Commons, CC BY● Meski bermasalah dan terlibat pidana, banyak politikus yang tidak mengundurkan diri dari jabatann...

Ibarat bom waktu di sawah: Mengapa pupuk dan pestisida bukan jawaban mengatasi dampak perubahan iklim

● Pupuk dan pestisida terbukti bisa menangkal efek perubahan iklim.● Namun fungsinya hanya sebagai ‘obat penghilang nyeri’ sesaat saja.● Tanpa perubahan kebijakan menuju ...

Bagaimana mencegah penyakit menular akibat banjir ketika pemerintah tak bisa diandalkan?

● Banjir meningkatkan risiko penyebaran penyakit menular pada manusia.● Bencana ini membawa kuman dan hewan pembawa penyakit lebih dekat dengan manusia, serta mengganggu sanitasi.● H...